Thermo Fisher Scientific (NYSE:TMO) opened its Cryo Electron Microscopy Drug Discovery Center in South San Francisco. The company introduced new culture media to support rapid Candida detection.

TMO's acquisitions and resilient pharma, biotech and diagnostics demand support growth, but currency swings and fierce competition remain risks.

THERMO Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution centre in Bracetown, County Meath, Ireland. The facility ...

The new center offers immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights.

Thermo Fisher Scientific is the world leader in serving science, and our mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life ...

Thermo Fisher Scientific Inc. (TMO) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 9:15 AM ESTCompany ParticipantsMarc Casper ...

Thermo Fisher Scientific Inc., has agreed to acquire a Swedish company for about $3.1 billion to expand its life sciences business. Thermo Fisher, a maker of medical and scientific devices with Lehigh ...

WALTHAM, Mass. & HILLSBORO, Ore.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and FEI Company (NASDAQ:FEIC), the leader in high-performance electron ...

Thermo Fisher Scientific, which describes itself as "the world leader in serving science," reports annual revenue exceeding $40 billion. The company provides a range of scientific products and ...

Lab and medical equipment company Thermo Fisher Scientific said Friday that it will buy imaging company FEI Co. for $4.2 billion in cash to bolster its offerings for the study of the structure of ...

WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD clinical research business of Thermo Fisher Scientific has been named Clinical Research Company of the Year at the 2022 PharmaTimes Clinical Researcher of ...

Thermo Electron and Fisher Scientific were both strong companies that were doing fine on their own. They had aggressive strategies of making acquisitions to consolidate their portions of the ...